Vigonvita Life Sciences Co., Ltd. — Proxy Solicitation & Information Statement 2026

Mar 2, 2026

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this notice, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this notice.

Vigonvita Life Sciences Co., Ltd.

蘇州旺山旺水生物醫藥股份有限公司

(a joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 2630)

NOTICE OF EXTRAORDINARY GENERAL MEETING

NOTICE IS HEREBY GIVEN that an extraordinary general meeting (the “EGM”) of Vigonvita Life Sciences Co., Ltd. (the “Company”) will be held at 8th Floor, Building A, No. 108, Yuxin Road, Suzhou Industrial Park District, Suzhou, PRC at 10:00 a.m. on Thursday, March 19, 2026 for the purpose of considering, and if thought fit, approving (with or without modifications) the following resolution:

BY WAY OF SPECIAL RESOLUTION

1. To consider and approve the adoption of the H Share Award Scheme and to approve the authorization to the Board to handle matters pertaining to the H Share Award Scheme.

By order of the Board

Vigonvita Life Sciences Co., Ltd.

Dr. Tian Guanghui

Chairman of the Board, Executive Director,

Chief Executive Officer and General Manager

Suzhou, the PRC, March 2, 2026

As at the date of this notice, the Board comprises Dr. Tian Guanghui and Dr. Hu Tianwen as executive Directors, Mr. Liu Haoxuan as non-executive Director, and Dr. Ju Dianwen, Ms. Cao Xinwen and Dr. Xu Hongxi as independent non-executive Directors.

---

• 2 -

Notes:

1. Unless otherwise indicated, capitalized terms used herein shall have the same meanings as those defined in the circular of the Company dated March 2, 2026.

2. For determining eligibility to attend and vote at the EGM, the register of members of H Shares of the Company will be closed from Monday, March 16, 2026 to Thursday, March 19, 2026, both days inclusive, during which period no transfer of H Shares will be registered. To be eligible for attending and voting at the EGM, all duly completed transfer forms accompanied by the relevant share certificates must be lodged with the Company’s H Share Registrar, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong not later than 4:30 p.m. on Friday, March 13, 2026 for registration. Shareholders whose names appear on the register of members of the Company on Thursday, March 19, 2026 shall be entitled to attend and vote at the EGM.

3. All votes of resolution at the EGM will be taken by poll pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”). The results of the poll will be published on the websites of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk) and the Company (www.vigonvita.cn) in accordance with the Listing Rules.

4. Any Shareholders entitled to attend and vote at the EGM can appoint one or more proxies to attend and vote at the EGM on his/her behalf. A proxy need not be a Shareholder of the Company. If more than one proxy is so appointed, the appointment shall specify the number and type of H Shares or Unlisted Shares in respect of which each proxy is so appointed.

5. Shareholders shall appoint their proxies in writing. The proxy form shall be signed by the Shareholder or his/her/its attorney who has been duly authorized in writing. If the Shareholder is a corporation, the proxy form shall be affixed with the corporation’s seal or signed by its legal representative, director, or its attorney duly authorized in writing. If the proxy form is signed by the attorney of the Shareholder, the power of attorney or other authorization document shall be notarized. The aforementioned documents must be lodged with the H Share Registrar, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong not less than 24 hours before the time appointed for holding the EGM (i.e. 10:00 a.m. on Wednesday, March 18, 2026 (Hong Kong time)) or any adjournment thereof in order for such documents to be valid. Completion and delivery of the proxy form shall not preclude a Shareholder of the Company from attending and voting in person at the EGM and, in such event, the instrument appointing a proxy shall be deemed to be revoked.

6. Shareholders are required to produce proof of identity when attending the EGM.

7. If a Shareholder appoints a proxy to attend the EGM, the proxy must present his/her identification documents and a power of attorney or other document signed by the appointor or his/her legal representative with the date of issuance. If a corporate Shareholder is represented at the EGM by a proxy, the proxy must present proof of identity and a notarized copy of the resolution passed by the Board or other authority or a notarized copy of the authorization issued by the corporate Shareholder.

8. In the case of joint Shareholders of any H Shares, the vote cast by the senior Shareholder, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint Shareholders, and for this purpose seniority shall be determined by the order in which the names of the relevant joint Shareholders stand on the register of members of the Company.

9. The EGM is expected to last for half a day. Shareholders attending (in person or by proxy) the EGM shall be responsible for their own traveling, accommodation and other expenses.

10. The contact details of the Company are as follows:

Address:
Vigonvita Life Sciences Co., Ltd.
8th Floor, Building A, No. 108,
Yuxin Road, Suzhou Industrial Park District, Suzhou, PRC

Liaison: Ms. Guo Ting
Email: ting.guo@vigonvita.cn

1. Details of the aforesaid resolution to be proposed at the EGM are set out in the circular of the Company dated March 2, 2026.